C&O Pharmaceuticals launch proprietary gastro-intestinal drug

C & O Pharmaceutical Technology has launched a new C&O branded gastro-intestinal drug, Domperidone Maleate tablets under the brand 'Youmalin' in China.

According to C&O, Domperidone Maleate is used in the treatment of gastric indigestion to improve gastric mobility. The drug helps to relieve symptoms such as bloating, abdominal pain, belch and flatulence caused by delayed gastric emptying, gastroesophageal reflux disease (GERD) and esophagitis; pyrosis and oral burning sensation caused by GERD, chronic and subacute gastritis caused by gastroesophageal mobility disorder; and diabetic gastroparesis and general nausea and vomiting. It was estimated that the market for Domperidone would exceed RMB 400 million.

The company further states that Domperidone has already been sold in many developed countries, but Domperidone Maleate had not been available in Mainland China until the launch of Youmalin. Moving forward, C&O is expected to launch a series of new drugs in China and according to stockbroking firm CIMB-GK, these series of launches have been factored into their target price of S$0.70.